Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication.

Gallego P, Rojas Á, Falcón G, Carbonero P, García-Lozano MR, Gil A, Grande L, Cremades O, Romero-Gómez M, Bautista JD, Del Campo JA.

Food Funct. 2019 Jun 19;10(6):3758-3767. doi: 10.1039/c9fo00733d.

PMID:
31179460
2.

Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.

Rojas-Feria M, Romero-García T, Fernández Caballero-Rico JÁ, Pastor Ramírez H, Avilés-Recio M, Castro-Fernandez M, Chueca Porcuna N, Romero-Gόmez M, García F, Grande L, Del Campo JA.

World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223.

3.

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Rodríguez-Hernández MA, González R, de la Rosa ÁJ, Gallego P, Ordóñez R, Navarro-Villarán E, Contreras L, Rodríguez-Arribas M, González-Gallego J, Álamo-Martínez JM, Marín-Gómez LM, Del Campo JA, Quiles JL, Fuentes JM, de la Cruz J, Mauriz JL, Padillo FJ, Muntané J.

J Cell Physiol. 2018 Jan;234(1):692-708. doi: 10.1002/jcp.26855. Epub 2018 Aug 21.

PMID:
30132846
4.

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).

Del Campo JA, Gallego-Durán R, Gallego P, Grande L.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E911. doi: 10.3390/ijms19030911. Review.

5.

Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype.

Rojas Á, Gallego P, Gil-Gómez A, Muñoz-Hernández R, Rojas L, Maldonado R, Gallego R, García-Valdecasas M, Del Campo JA, Bautista JD, Romero-Gómez M.

Ann Hepatol. 2018 Mar 1;17(2):242-249. doi: 10.5604/01.3001.0010.8642.

6.

Role of inflammatory response in liver diseases: Therapeutic strategies.

Del Campo JA, Gallego P, Grande L.

World J Hepatol. 2018 Jan 27;10(1):1-7. doi: 10.4254/wjh.v10.i1.1. Review.

7.

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.

Del Campo JA, García-Valdecasas M, Gil-Gómez A, Rojas Á, Gallego P, Ampuero J, Gallego-Durán R, Pastor H, Grande L, Padillo FJ, Muntané J, Romero-Gómez M.

PLoS One. 2018 Jan 31;13(1):e0191805. doi: 10.1371/journal.pone.0191805. eCollection 2018.

8.

Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience.

Del Campo JA, Parra-Sánchez M, Figueruela B, García-Rey S, Quer J, Gregori J, Bernal S, Grande L, Palomares JC, Romero-Gómez M.

Int J Infect Dis. 2018 Feb;67:114-117. doi: 10.1016/j.ijid.2017.12.016. Epub 2017 Dec 15.

9.

Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets.

Rojas Á, Del Campo JA, Clement S, Lemasson M, García-Valdecasas M, Gil-Gómez A, Ranchal I, Bartosch B, Bautista JD, Rosenberg AR, Negro F, Romero-Gómez M.

Sci Rep. 2016 Aug 22;6:31777. doi: 10.1038/srep31777.

10.

Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.

Ampuero J, Ranchal I, Gallego-Durán R, Pareja MJ, Del Campo JA, Pastor-Ramírez H, Rico MC, Picón R, Pastor L, García-Monzón C, Andrade R, Romero-Gómez M.

J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.

PMID:
26946071
11.

Reply to contribution on the topic of hypovitaminosis D in chronic hepatitis C.

Villar LM, Lampe E, de Almeida AJ, de Paula Scalioni L, Lewis-Ximenez LL, Miguel JC, del Campo JA, Ranchal I, Villela-Nogueira CA, Romero-Gomez M.

Ann Hepatol. 2016 Jan-Feb;15(1):139-40. No abstract available.

12.

Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies.

Del Campo JA, Romero-Gómez M.

World J Gastroenterol. 2015 Oct 14;21(38):10776-82. doi: 10.3748/wjg.v21.i38.10776. Review.

13.

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

Ampuero J, Del Campo JA, Rojas L, Calleja JL, Cabezas J, Lens S, Crespo J, Forns X, Andrade RJ, Fernández I, Buti M, Millán R, Romero-Gómez M.

J Clin Virol. 2015 Jul;68:56-60. doi: 10.1016/j.jcv.2015.05.010. Epub 2015 May 14.

PMID:
26071337
14.

Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients.

Melo-Villar L, Lampe E, de Almeida AJ, de P Scalioni L, Lewis-Ximenez LL, Miguel JC, Del Campo JA, Ranchal I, Villela-Nogueira CA, Romero-Gomez M.

Ann Hepatol. 2015 Jul-Aug;14(4):457-63.

15.

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection.

Ampuero J, del Campo JA, Rojas L, García-Lozano RJ, Buti M, Solá R, Forns X, Moreno-Otero R, Andrade R, Diago M, Salmerón J, Rodrigo L, Pons JA, Navarro JM, Calleja JL, García-Samaniego J, García-Valdecasas M, Rojas Á, Millán R, González-Escribano MF, Romero-Gómez M.

Genes Immun. 2015 Jul-Aug;16(5):297-300. doi: 10.1038/gene.2015.14. Epub 2015 Apr 30.

PMID:
25928882
16.

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.

Quer J, Gregori J, Rodríguez-Frias F, Buti M, Madejon A, Perez-del-Pulgar S, Garcia-Cehic D, Casillas R, Blasi M, Homs M, Tabernero D, Alvarez-Tejado M, Muñoz JM, Cubero M, Caballero A, del Campo JA, Domingo E, Belmonte I, Nieto L, Lens S, Muñoz-de-Rueda P, Sanz-Cameno P, Sauleda S, Bes M, Gomez J, Briones C, Perales C, Sheldon J, Castells L, Viladomiu L, Salmeron J, Ruiz-Extremera A, Quiles-Pérez R, Moreno-Otero R, López-Rodríguez R, Allende H, Romero-Gómez M, Guardia J, Esteban R, Garcia-Samaniego J, Forns X, Esteban JI.

J Clin Microbiol. 2015 Jan;53(1):219-26. doi: 10.1128/JCM.02093-14. Epub 2014 Nov 5. Erratum in: J Clin Microbiol. 2016 Jul;54(7):1933.

17.

THDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapy.

Díaz-Herrero MM, del Campo JA, Carbonero-Aguilar P, Vega-Pérez JM, Iglesias-Guerra F, Periñán I, Miñano FJ, Bautista J, Romero-Gómez M.

PLoS One. 2014 Oct 17;9(10):e109787. doi: 10.1371/journal.pone.0109787. eCollection 2014.

18.

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.

Ampuero J, Del Campo JA, Rojas L, García-Lozano JR, Solá R, Andrade R, Pons JA, Navarro JM, Calleja JL, Buti M, González-Escribano MF, Forns X, Diago M, García-Samaniego J, Romero-Gómez M.

Ann Hepatol. 2014 Jul-Aug;13(4):356-63.

19.

Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro.

Rojas Á, del Campo JA, Maraver M, Aparcero R, García-Valdecasas M, Diago M, Carmona I, Andrade RJ, Solà R, Romero-Gómez M.

J Viral Hepat. 2014 Jan;21(1):19-24. doi: 10.1111/jvh.12209. Epub 2013 Nov 4.

PMID:
24188401
20.

Association between vitamin D and hepatitis C virus infection: a meta-analysis.

Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M.

World J Gastroenterol. 2013 Sep 21;19(35):5917-24. doi: 10.3748/wjg.v19.i35.5917. Review.

21.

Insulin resistance, telaprevir, and virological response in hepatitis C: the debate must go on.

Romero-Gómez M, Del Campo JA.

Hepatology. 2013 Dec;58(6):1874-6. doi: 10.1002/hep.26642. Epub 2013 Oct 24. No abstract available.

PMID:
23913755
22.

Role of diabetes mellitus on hepatic encephalopathy.

Ampuero J, Ranchal I, del Mar Díaz-Herrero M, del Campo JA, Bautista JD, Romero-Gómez M.

Metab Brain Dis. 2013 Jun;28(2):277-9. doi: 10.1007/s11011-012-9354-2. Epub 2012 Nov 24. Review.

PMID:
23180316
23.

Metformin inhibits glutaminase activity and protects against hepatic encephalopathy.

Ampuero J, Ranchal I, Nuñez D, Díaz-Herrero Mdel M, Maraver M, del Campo JA, Rojas Á, Camacho I, Figueruela B, Bautista JD, Romero-Gómez M.

PLoS One. 2012;7(11):e49279. doi: 10.1371/journal.pone.0049279. Epub 2012 Nov 15.

24.

The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance.

del Campo JA, García-Valdecasas M, Rojas L, Rojas Á, Romero-Gómez M.

PLoS One. 2012;7(10):e47904. doi: 10.1371/journal.pone.0047904. Epub 2012 Oct 25.

25.

Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism.

Del Campo JA, Ampuero J, Rojas L, Conde M, Rojas A, Maraver M, Millán R, García-Valdecasas M, García-Lozano JR, González-Escribano MF, Romero-Gómez M.

Aliment Pharmacol Ther. 2013 Jan;37(1):74-80. doi: 10.1111/apt.12113. Epub 2012 Nov 5.

26.

Entry of hepatitis C virus into the cell: a therapeutic target.

Del Campo JA, Rojas Á, Romero-Gómez M.

World J Gastroenterol. 2012 Sep 7;18(33):4481-5. doi: 10.3748/wjg.v18.i33.4481.

27.

Insulin resistance impairs viral dynamics independently of ethnicity or genotypes.

Eslam M, Aparcero R, Mousa YI, Grande L, Shaker Y, Ali A, Del Campo JA, Khattab MA, Romero-Gomez M.

J Clin Gastroenterol. 2012 Mar;46(3):228-34. doi: 10.1097/MCG.0b013e31822a2dc6.

PMID:
22298085
28.

Experimental models for hepatic encephalopathy.

Díaz-Gómez D, Jover M, del-Campo JA, Galindo A, Romero-Gómez M.

Rev Esp Enferm Dig. 2011 Oct;103(10):536-41. Review. English, Spanish. No abstract available.

29.

Use of HOMA-IR in hepatitis C.

Eslam M, Kawaguchi T, Del Campo JA, Sata M, Khattab MA, Romero-Gomez M.

J Viral Hepat. 2011 Oct;18(10):675-84. doi: 10.1111/j.1365-2893.2011.01474.x. Epub 2011 May 25. Review.

PMID:
21914084
30.

Meta-analysis: insulin resistance and sustained virological response in hepatitis C.

Eslam M, Aparcero R, Kawaguchi T, Del Campo JA, Sata M, Khattab MA, Romero-Gomez M.

Aliment Pharmacol Ther. 2011 Aug;34(3):297-305. doi: 10.1111/j.1365-2036.2011.04716.x. Epub 2011 May 29.

31.

Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.

Romero-Gómez M, Jover M, Del Campo JA, Royo JL, Hoyas E, Galán JJ, Montoliu C, Baccaro E, Guevara M, Córdoba J, Soriano G, Navarro JM, Martínez-Sierra C, Grande L, Galindo A, Mira E, Mañes S, Ruiz A.

Ann Intern Med. 2010 Sep 7;153(5):281-8. doi: 10.7326/0003-4819-153-5-201009070-00002.

PMID:
20820037
32.

Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.

del Campo JA, López RA, Romero-Gómez M.

Dig Dis. 2010;28(1):285-93. doi: 10.1159/000282104. Epub 2010 May 7. Review.

PMID:
20460925
33.

Steatosis and insulin resistance in hepatitis C: a way out for the virus?

Del Campo JA, Romero-Gómez M.

World J Gastroenterol. 2009 Oct 28;15(40):5014-9. Review.

35.

Outdoor cultivation of microalgae for carotenoid production: current state and perspectives.

Del Campo JA, García-González M, Guerrero MG.

Appl Microbiol Biotechnol. 2007 Apr;74(6):1163-74. Epub 2007 Feb 3. Review.

PMID:
17277962
36.
37.

Outdoor cultivation of lutein-rich cells of Muriellopsis sp. in open ponds.

Blanco AM, Moreno J, Del Campo JA, Rivas J, Guerrero MG.

Appl Microbiol Biotechnol. 2007 Jan;73(6):1259-66. Epub 2006 Oct 11.

PMID:
17033775
38.

Genetic dissection of nutritional copper signaling in chlamydomonas distinguishes regulatory and target genes.

Eriksson M, Moseley JL, Tottey S, Del Campo JA, Quinn J, Kim Y, Merchant S.

Genetics. 2004 Oct;168(2):795-807.

39.

Evaluation of oxygen response involving differential gene expression in Chlamydomonas reinhardtii.

Del Campo JA, Quinn JM, Merchant S.

Methods Enzymol. 2004;381:604-17. No abstract available.

PMID:
15063701
40.

Accumulation of astaxanthin and lutein in Chlorella zofingiensis (Chlorophyta).

Del Campo JA, Rodríguez H, Moreno J, Vargas MA, Rivas J, Guerrero MG.

Appl Microbiol Biotechnol. 2004 Jun;64(6):848-54. Epub 2003 Dec 20.

PMID:
14689249
41.

Lutein production by Muriellopsis sp. in an outdoor tubular photobioreactor.

Del Campo JA, Rodríguez H, Moreno J, Vargas MA, Rivas J, Guerrero MG.

J Biotechnol. 2001 Feb 23;85(3):289-95.

PMID:
11173095
42.

Carotenoid content of chlorophycean microalgae: factors determining lutein accumulation in Muriellopsis sp. (Chlorophyta).

Del Campo JA, Moreno J, Rodríguez H, Vargas MA, Rivas J, Guerrero MG.

J Biotechnol. 2000 Jan 7;76(1):51-9.

PMID:
10784296
43.

Self-mutilating behaviour of psychiatric inpatients.

Nijman HL, Dautzenberg M, Merckelbach HL, Jung P, Wessel I, del Campo JA.

Eur Psychiatry. 1999 Mar;14(1):4-10.

PMID:
10572319

Supplemental Content

Loading ...
Support Center